The so-called 'Most Favored Nations' rule would set drug pricing for Medicare in line with the prices paid by other nations, ...

The European Union should allow drug prices to rise to U.S. levels in order to attract investment, the bosses of two European ...

CEOs from European drugmakers Sanofi and Novartis have inked a letter in The Financial Times urging the European Union to set ...

Top Swiss officials will this week test whether big commitments to the U.S. can help secure relief from import tariffs, after ...

Roche AG has become the latest pharmaceutical company to respond to the Trump administration’s threat to impose tariffs, saying it will invest $50 billion in drug and diagnostics manufacturing in the ...

The move will also create 12,000 new jobs across the United States, with 6,500 in construction and 1,000 at “new and expanded ...

Novartis AG NVS, a Swiss pharma giant, is scheduled to report first-quarter 2025 results on April 29, 2025. The Zacks ...

Hikma buys rights to FDA-approved cancer treatment trametinib, a generic version of Novartis' (NVS) Mekinist, with 180 days ...

A three-judge panel wrestled Thursday with Novartis AG’s challenge against the FDA over its approval of a generic version of ...

Shares MSCI Switzerland ETF's high allocation to Nestle, Roche, and Novartis poses diversification risks. Read why EWL is a ...

Real Chemistry, a 2024 MM+M Agency 100 honoree, appointed Cali Howitt, PhD, as president of U.S. medical and executive leader for its promotional and medical affairs business in the U.S. General ...